{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Use of Benzodiazepines as Anxiolytics in Neonates: Are We There Yet?

Description

This article has been approved by the National Association for Neonatal Nurses Certification Board for Category B credit toward recertification as an NNP.

Purpose of Activity

To become familiar with the pharmacologic effects of benzodiazepines that are used for infant sedation.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Recognize the assessment of sedation in the neonate.
  2. Identify the pharmacokinetics of benzodiazepines (BZDs) in the neonate.
  3. Identify the use of benzodiazepines (BZDs) in the neonate.
Price: $24.95

Credits:

  • ANCC 3.0 CH
  • DC - BON 3.0 CH
  • FL - BON 3.0 CH

Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
--------------------------------------------------
This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia and Florida #50-1223. Your certificate is valid in all states.





Test Code: ANC0314
Published: Apr 2014
Expires: 3/5/2021
Passing Score: 13/18 (72%)
Authors: Michelle A. Nelson, MSN, RN, NNP-BC; Wanda T. Bradshaw, MSN, RN, NNP-BC, PNP, CCRN